首页> 外文期刊>Carcinogenesis >Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore
【24h】

Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore

机译:穿心莲内酯通过亲环蛋白D介导的线粒体通透性过渡孔诱导人肝癌细胞自噬性细胞死亡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Liver cancer is the third leading cause of cancer death worldwide and about half of the patients with liver cancer require adjuvant therapy after surgical resection. Therefore, development of novel agents to eradicate cancer cells may constitute a viable approach to treat patients with liver cancer. Andrographolide, a diterpenoid lactone isolated from Andrographis paniculata, is known to possess potent antioxidant, anti-inflammatory, antineoplastic and antiviral properties. In this study, we investigated the cytotoxic effect of andrographolide on human liver cancer cells and explored the cell death mechanism. Andrographolide induced a cell death distinct from apoptosis in multiple human liver cancer cells. The death was characterized by autophagy as evidenced by the accumulation of LC3 II and autophagosomes, and the formation of puncta GFP-LC3. This autophagy as well as cytotoxicity caused by andrographolide could be effectively prevented by 3-methyladenine (a chemical inhibitor of autophagy). Mechanistic study indicated that andrographolide induced autophagic cell death by disruption of mitochondrial transmembrane potential and elevation of reactive oxygen species, which were correlated with mitochondrial permeability transition pore Inhibition of cyclophilin D (a component of MPTP) by cyclosporin A or abrogation of its expression by small interfering RNA significantly suppressed the cytotoxicity of andrographolide, suggesting that cyclophilin D may play an important role in mediating andrographolide-induced cytotoxicity. Taken together, our findings unveil a novel mechanism of drug action by andrographolide in liver cancer cells and suggest that andrographolide may represent a promising novel agent in the treatment of liver cancer.
机译:肝癌是全球第三大导致癌症死亡的主要原因,大约一半的肝癌患者在手术切除后需要辅助治疗。因此,开发消灭癌细胞的新型药物可能构成治疗肝癌患者的可行方法。穿心莲内酯是一种从穿心莲中分离出的二萜类内酯,已知具有有效的抗氧化剂,抗炎,抗肿瘤和抗病毒特性。在这项研究中,我们调查了穿心莲内酯对人肝癌细胞的细胞毒性作用,并探讨了细胞死亡机制。穿心莲内酯在多种人类肝癌细胞中诱导了不同于凋亡的细胞死亡。死亡的特征是自噬,如LC3 II和自噬小体的积累以及点状GFP-LC3的形成所证明。 3-甲基腺嘌呤(自噬的化学抑制剂)可有效预防穿心莲内酯引起的这种自噬以及细胞毒性。机理研究表明,穿心莲内酯可通过破坏线粒体跨膜电位和增加活性氧来诱导自噬细胞死亡,这与线粒体通透性过渡孔抑制环孢菌素D(MPTP的一部分)或通过小幅度废除其表达有关干扰RNA显着抑制穿心莲内酯的细胞毒性,这表明亲环蛋白D可能在介导穿心莲内酯诱导的细胞毒性中起重要作用。综上所述,我们的发现揭示了穿心莲内酯在肝癌细胞中的新型药物作用机制,并暗示穿心莲内酯可能代表着有前途的新型药物治疗肝癌。

著录项

  • 来源
    《Carcinogenesis》 |2012年第11期|p.2190-2198|共9页
  • 作者单位

    1 College of Food Science and Biotechnology, Zhejiang Gongshang University Hangzhou 310035, China,and 2 Department of Food Science and Nutrition, Zhejiang University Hangzhou 310058, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号